Key Segments:
By Disease Type
-
Covid-19
-
Ebola
-
Influenza
-
Hepatitis
-
Others
By Booking Channel
-
Online Booking
-
In Person Booking
By Tourist Type
-
Domestic
-
International
By Tour Type
-
Independent Traveler
-
Tour Group
-
Package Traveller
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
Egypt
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the Travel Vaccines Market in 2025.
The “Influenza” segment dominated during the projected period.
Rising international travel, increasing awareness of preventable diseases, and government vaccination mandates drive the Travel Vaccines Market.
The Travel Vaccines Market size was USD 5.22 Billion in 2025 and is expected to reach USD 12.78 Billion by 2035.
The Travel Vaccines Market is expected to grow at a CAGR of 9.37% from 2026-2035.